Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK
Human Psychopharmacology July 1, 2015 Lynn T. Singer, Derek G. Moore, Meeyoung O. Min et al. 16 citations
This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, “ecstasy”) on infant development.